Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian population

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Narooie Nejad, Mehrnaz ^a   Moossavi, Maryam ^b   Torkamanzehi, Adam ^b   Moghtaderi, Ali ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRANIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; IRAN; MULTICENTER STUDY;

ALLELES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL;

EID: 84922343580     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/427519     Document Type: Article

References (38)

1. M. Muñoz-Culla, H. Irizar, and D. Otaegui, "The genetics of multiple sclerosis: review of current and emerging candidates", Application of Clinical Genetics, vol. 6, pp. 63-73, 2013.
2. M. M. Goldenberg, "Multiple sclerosis review", P & T, vol. 37, no. 3, pp. 175-184, 2012.
3. J.-I. Satoh and H. Tabunoki, "Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes", Multiple Sclerosis, vol. 19, no. 8, pp. 1035-1045, 2013.
4. N. A. Patsopoulos, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist et al., "Genome-wide meta-analysis identifies novelmultiple sclerosis susceptibility loci", Annals of Neurology, vol. 70, no. 6, pp. 897-912, 2011.
5. P. J. Malloy, T. R. Eccleshall, C. Gross, L. Van Maldergem, R. Bouillon, and D. Feldman, "Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness", Journal of Clinical Investigation, vol. 99, no. 2, pp. 297-304, 1997.
6. 3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers", Molecular and Cellular Biology, vol. 14, no. 5, pp. 3329-3338, 1994.
7. L. L. Issa, G. M. Leong, and J. A. Eisman, "Molecularmechanism of vitamin D receptor action", Inflammation Research, vol. 47, no. 12, pp. 451-475, 1998.
8. N. A. Morrison, J. C. Qi, A. Tokita et al., "Prediction of bone density from vitamin D receptor alleles", Nature, vol. 367, no. 6460, pp. 284-287, 1994.
9. M. Hewison, "Vitamin D and the immune system: new perspectives on an old theme", Rheumatic Disease Clinics of North America, vol. 38, no. 1, pp. 125-139, 2012.
10. P. W. Jurutka, L. Bartik, G. K. Whitfield et al., "Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands", Journal of Bone and Mineral Research, vol. 22, supplement 2, pp. V2-V10, 2007.
11. E. Garcion, N. Wion-Barbot, C. N. Montero-Menei, F. Berger, and D. Wion, "New clues about vitamin D functions in the nervous system", Trends in Endocrinology & Metabolism, vol. 13, no. 3, pp. 100-105, 2002.
12. + cells in the draining lymph nodes", The Journal of Immunology, vol. 179, no. 9, pp. 6273-6283, 2007.
13. + T cells to enhance the development of Th2 cells", Journal of Immunology, vol. 167, no. 9, pp. 4974-4980, 2001.
14. H. M. Schrijver, T. Hooper-Van Veen, M. J. Van Belzen et al., "Polymorphisms in the genes encoding interferon-γ and interferon-γ receptors in multiple sclerosis", European Journal of Immunogenetics, vol. 31, no. 3, pp. 133-140, 2004.
15. S. Chen, G. P. Sims, X. C. Xiao, Y. G. Yue, S. Chen, and P. E. Lipsky, "Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation", Journal of Immunology, vol. 179, no. 3, pp. 1634-1647, 2007.
16. J. Nieves, F. Cosman, J. Herbert, V. Shen, and R. Lindsay, "High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis", Neurology, vol. 44, no. 9, pp. 1687-1692, 1994.
17. M. T. Cantorna, C. E. Hayes, and H. F. Deluca, "1, 25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis", Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 7861-7864, 1996.
18. 3 to suppress experimental autoimmune encephalomyelitis in mice", Archives of Biochemistry and Biophysics, vol. 408, no. 2, pp. 200-204, 2002.
19. K. C. Simon, K. L. Munger, X. Yang, and A. Ascherio, gPolymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis, Multiple Sclerosis, vol. 16, no. 2, pp. 133-138, 2010.
20. V. Škrabiíć, T. Zemunik, M. Šitum, and J. Terziíc, "Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in the Dalmatian population", Diabetes Research and Clinical Practice, vol. 59, no. 1, pp. 31-35, 2003.
21. C.-M. Huang, M.-C. Wu, J.-Y. Wu, and F.-J. Tsai, "Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus", Lupus, vol. 11, no. 1, pp. 31-34, 2002.
22. M. Niino, T. Fukazawa, I. Yabe, S. Kikuchi, H. Sasaki, and K. Tashiro, "Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles", Journal of the Neurological Sciences, vol. 177, no. 1, pp. 65-71, 2000.
23. C. Sioka, S. Papakonstantinou, S. Markoula et al., "Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece", Journal of Negative Results in BioMedicine, vol. 10, no. 1, article 3, 2011.
24. C. H. Polman, S. C. Reingold, G. Edan et al., "Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria"", Annals of Neurology, vol. 58, no. 6, pp. 840-846, 2005.
25. M. Mohammadoo-Khorasani, S. Salimi, E. Tabatabai, M. Sandoughi, and Z. Zakeri, "Association of interleukin-1 receptor antagonist gene 86bp VNTR polymorphism with systemic lupus erythematosus in south east of Iran", Zahedan Journal of Research in Medical Sciences, vol. 16, no. 12, pp. 51-54, 2014.
26. C. O'Gorman, R. Lucas, and B. Taylor, "Environmental risk factors formultiple sclerosis: a review with a focus onmolecular mechanisms", International Journal of Molecular Sciences, vol. 13, no. 9, pp. 11718-11752, 2012.
27. B. M. Van Amerongen, C. D. Dijkstra, P. Lips, and C. H. Polman, "Multiple sclerosis and vitamin D: an update", European Journal of Clinical Nutrition, vol. 58, no. 8, pp. 1095-1109, 2004.
28. A. Moghtaderi, G. H. Tamadon, and F. Haghighi, "25-hydroxyvitamin D3 concentration in serum and cerebrospinal fluid of patients with remitting-relapse multiple sclerosis", Prague Medical Report, vol. 114, no. 3, pp. 162-171, 2013.
29. C. J. Willer, D. A. Dyment, A. D. Sadovnick, P. M. Rothwell, T. J. Murray, and G. C. Ebers, "Timing of birth and risk of multiple sclerosis: population based study", British Medical Journal, vol. 330, no. 7483, pp. 120-123, 2005.
30. A. Ascherio, K. L. Munger, and K. C. Simon, "Vitamin D and multiple sclerosis", The Lancet Neurology, vol. 9, no. 6, pp. 599-612, 2010.
31. M. Etemadifar, S. Sajjadi, Z. Nasr et al., "Epidemiology of multiple sclerosis in iran: a systematic review", European Neurology, vol. 70, no. 5-6, pp. 356-363, 2013.
32. A. Moghtaderi, F. Rakhshanizadeh, and S. Shahraki-Ibrahimi, "Incidence and prevalence of multiple sclerosis in southeastern Iran", Clinical Neurology and Neurosurgery, vol. 115, no. 3, pp. 304-308, 2013.
33. L. K. Durrin, R. W. Haile, S. A. Ingles, and G. A. Coetzee, "Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability", Biochimica et Biophysica Acta. Molecular Basis of Disease, vol. 1453, no. 3, pp. 311-320, 1999.
34. J. Smolders, J. Damoiseaux, P. Menheere, J. W. C. Tervaert, and R. Hupperts, "Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis", Annals of the New York Academy of Sciences, vol. 1173, no. 1, pp. 515-520, 2009.
35. T. Fukazawa, I. Yabe, S. Kikuchi et al., "Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese", Journal of the Neurological Sciences, vol. 166, no. 1, pp. 47-52, 1999.
36. L. Tajouri, M. Ovcaric, R. Curtain et al., "Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population", Journal of Neurogenetics, vol. 19, no. 1, pp. 25-38, 2005.
37. J. M. Partridge, S. J. M. Weatherby, J. A. Woolmore et al., "Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes", Neurology, vol. 62, no. 12, pp. 2323-2325, 2004.
38. A. G. Uitterlinden, Y. Fang, J. B. J. Van Meurs, H. Van Leeuwen, and H. A. P. Pols, "Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states", The Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 187-193, 2004.